When was TreeFrog Therapeutics founded?

TreeFrog Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is TreeFrog Therapeutics located?

TreeFrog Therapeutics is headquartered in Talence, France.

How many employees does TreeFrog Therapeutics have?

As of Jun 30, 2026, the latest employee count at TreeFrog Therapeutics is 160.

Is TreeFrog Therapeutics a funded company?

TreeFrog Therapeutics is a funded company, having raised a total of $84.2M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 10, 2019.

When was the latest funding round of TreeFrog Therapeutics?

TreeFrog Therapeutics' latest funding was a $***** Venture Debt round on May 27, 2025, with participation from 1 investor.

Where does TreeFrog Therapeutics rank among its competitors?

TreeFrog Therapeutics ranks 7th amongst 128 active competitors, of which 46 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Pandorum, which secured $429K in Mar, 2026.

Who are the top competitors of TreeFrog Therapeutics?

TreeFrog Therapeutics' top competitors include Pandorum, Aspen Neuroscience and Blue Rock Therapeutics. Among them, Pandorum secured the most recent funding round in March, 2026.

TreeFrog Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

TreeFrog Therapeutics is developing stem cells and organoids using proprietary technology to enable the development of cell therapies. It enables the younger cells to mitigate mutational risks. They have developed organoids from pluripotent stem cells.

Website: treefrog.fr
Social
Phone Number: +33 **********

Key Metrics

Founded Year

2018

Location

Talence, France

Stage

Series B

Total Funding

$84.2M in 8 rounds

Latest Funding Round

Venture Debt, May 27, 2025, $*****

Investors

XAnge & 13 more

Ranked

7^th among 128 active competitors

Employee Count

160 as on Jun 30, 2026

Similar Companies

Pandorum & 146 more

View TreeFrog Therapeutics' full profile

TreeFrog Therapeutics has raised a total funding of $84.2M over 8 rounds. Its first funding round was on Jan 10, 2019. Its latest funding round was a Venture Debt round on May 27, 2025 for $*****. 1 investor participated in its latest round. TreeFrog Therapeutics has 14 institutional investors.

Here is the list of recent funding rounds of TreeFrog Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 27, 2025	5883680	Venture Debt	5196359	7273138	2824823	6226326
Oct 2021	9222509	Grant (prize money)	2263190	8059264	7958032	EIC Fund
Sep 13, 2021	6759486	Series B	3900454	5417042	XAnge & 2 more	2139280

Access funding benchmarks and valuations. Sign up today!

View details of TreeFrog Therapeutics's funding rounds and investors

The founders of TreeFrog Therapeutics is Kevin Alessandri.

Here are the details of TreeFrog Therapeutics' key team members:

Kevin Alessandri: Co-Founder & CTO of TreeFrog Therapeutics.

View details of TreeFrog Therapeutics's Founder profiles and Board Members

TreeFrog Therapeutics' employee count trend

TreeFrog Therapeutics has 160 employees as of Jun 26. Here is TreeFrog Therapeutics's employee count trend over the years:

Employee count trend for TreeFrog Therapeutics

Uncover TreeFrog Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TreeFrog Therapeutics include Pandorum, Aspen Neuroscience and Blue Rock Therapeutics. Here is the list of Top 10 competitors of TreeFrog Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pandorum 2011, Bengaluru (India), Series B	Developer of regenerative medicine and 3D tissues	$52.1M	Indian Angel Network, BTB Venture & 88 others	65/100
2nd	Aspen Neuroscience 2018, San Diego (United States), Series C	Provider of genomic-based personalised pluripotent stem cell therapy	$339M	Orbimed, Revelation Partners & 22 others	65/100
3rd	Blue Rock Therapeutics 2016, Boston (United States), Acquired	Stem cell therapies for cardiovascular and neurological diseases	$225M	Versant Ventures, Leaps by Bayer & 1 others	62/100
4th	Avita Medical 1992, Cambridge (United Kingdom), Public	Regenerative and Respiratory Medicine product company	-	Orbimed, BioScience Managers & 6 others	59/100
5th	Orthofix 1980, Lewisville (United States), Public	Developer of reconstructive and regenerative solutions for bone-related conditions	-	-	59/100
6th	Stellular Bio 2014, Watertown (United States), Series A	Developer of a platform for producing allogeneic, stem-cell-derived platelet-like cells	$37.5M	Vivo Capital, Qiming & 5 others	59/100
7th	TreeFrog Therapeutics 2018, Talence (France), Series B	Developer of stem cells and organoids using proprietary technology	$84.2M	Leonard Green and Partners, European Investment Bank ... & 12 others	59/100
8th	Organogenesis 1985, Canton (United States), Public	Regenerative tissue innovations for advanced wound care and surgical solutions	$30M	Eastward Capital Partners, Spring St. Group ... & 2 others	59/100
9th	Ensoma 2019, Boston (United States), Series B	Developer of in vivo hematopoietic stem cell engineering for genomic medicine	$205M	5AM Ventures, Arix Bioscience & 18 others	58/100
10th	Trailhead Biosystems 2015, Beachwood (United States), Series B	Developer of cell therapies for the treatment of multiple diseases	$97.1M	MAK Capital, BioEnterprise & 1 others	57/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on TreeFrog Therapeutics's competitors? Click here to see the top ones

TreeFrog Therapeutics has made no investments or acquisitions yet.

Here is the latest report on TreeFrog Therapeutics's geography:

Free

France Tech Semi Annual Funding Report

Edition: H1, 2026 (41 Pages)

View all reports related to TreeFrog Therapeutics

Media has covered TreeFrog Therapeutics for a total of 4 events in the last 1 year, 2 of them have been about company updates and 2 about people movement.